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3D AND BIO-PRINTING AS AN EFFICIENT AND SAFE ALTERNATIVE TO
TRADITIONAL METHODS AND MATERIALS IN CARDIOVASCULAR DISEASES
ABSTRACT
Background: Cardiovascular diseases are the leading cause of death globally. Therefore, there is
the need for more resources to be poured into the research of more treatment options, diagnostic
methods and preventative steps for patients. Though several technological advancements are
being made in the world of medicine, it is not a bad idea to look at other avenues that have great
potential to improve patient outcomes in cardiovascular diseases. 3D and bioprinting, though a
relatively new technology in the world of medicine, is showing a promising future. It is already
being applied in the field of orthopedic surgery and other specialties are jumping on this bandwagon as well.
Purpose: The question at hand that this literature review seeks to answer is that, can 3D and
bioprinting serve as an efficient and safe alternative to traditional methods and materials in
cardiovascular diseases?
Methods: In an attempt to answer this question, a comprehensive literature review was
conducted via Google Scholar, Google and Trip Database by using the search terms, 3D printing,
bioprinting, tissue engineering, cardiovascular diseases, and orthopedic implants, to name a few.
Inclusion criteria were primary research, clinical trials, and exclusion criteria were studies before
2017 and systematic reviews.
Conclusions: Looking at some of the marvelous already performed and ongoing studies, there is
a strong potential for 3D and bioprinting to become a potential alternative to traditional methods
and materials in cardiovascular diseases in the near future. This new technological advancement
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just needs time, dedication and hard work to bear relevant fruit in realm of cardiovascular
diseases.
Keywords: 3D printing, 3D bioprinting, applications, cardiovascular diseases

3D AND BIO-PRINTING AS AN EFFICIENT AND SAFE ALTERNATIVE TO
TRADITIONAL METHODS AND MATERIALS IN CARDIOVASCULAR DISEASES

INTRODUCTION
According to the World Health Organization (WHO), cardiovascular disease is the leading
cause of death globally, claiming an estimated 17.9 million lives per year and with coronary artery
diseases alone afflicting more than 16 million American adults. Looking at the encouraging
advancements in the field of medicine globally, the treatment of cardiovascular diseases is getting
better, but there is still more room for improvement. Current traditional methods and materials
used in treating cardiovascular diseases have shortcomings as is expected with almost any
treatment method. As such, there is the need for safe and efficient alternatives especially in medical
situations where the traditional routes are not as beneficial to the patient. This is where 3D and
bio-printing have promise in becoming effective alternatives. 3D printing is basically the creation
of three-dimensional objects from a computer aided design (CAD) model or digital 3D model.1,2
3D printing and its variety of applications are no strangers to the world of engineering and it is
amazing to see 3D printing rearing its head in the field of medicine through medical engineering.
Its uses are seen in a number of ways in specialties such as orthopedics, plastics/dermatology,
cardiovascular, surgery etc. Therefore, 3D and bioprinting has great potential to serve as an
efficient and safe alternative to the traditional methods and materials in cardiovascular diseases.
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In the field of medicine, the priority is to prevent or fix medical problems with little to no
harm to the patient. There have therefore been years of work and dedication put into research and
experimentations in order to come up with established standard methods and materials to fulfil this
priority. These traditional ways of doing things in the medical world seem to work most of the
time with little to no complications (given that everything goes as planned). But in cases where
these traditional ways are not optimum for the patient, it important to have other safe and efficient
options to present and have available for patients. In the field of medicine, the application of 3D
printing can be seen in radiology to create a 3D model of a patient’s spine to aid in surgical
planning, or even in dentistry to produce tooth crowns that fit perfectly in a patient’s mouth.3
Another current application of 3D printing is in the field of orthopedic surgery, where 3D joint
implants for the knee and ankle are being used in joint replacement surgeries instead of the standard
biocompatible artificial joints such as titanium, stainless steel or cobalt joint implants and
encouraging results are being observed and recorded.
In the area of cardiovascular diseases, 3D and bioprinting are being researched for their
potential to produce cardiac tissues that can make up the myocardium, heart valves that can grow
as the patient ages, and in vasculature with coronary arteries. Though 3D printing is fairly new and
its applications still require a lot of research, clinical trials and observations, it has great
applications to come. A future application of 3D and bioprinting is in the area of organ transplants.
It comes as no surprise that the demand for transplant organs by patients with end stage organ
failure diseases exceed the number of available organs from donors. And even with a successful
organ transplant, there is a chance of rejection by the patient. This is one of the areas where an
efficient and safe alternate to this traditional route might be very beneficial. Imagine if not all
patients in end-stage organ diseases had to qualify and wait on a transplant list and could have

Asare-Ose 6
access to another artificial organ that could work safely and efficiently through bio-printing. This
could even benefit the patients who are not able to qualify for these very competitive transplant
lists. It is obvious that this kind of medical advancement with bio-printing of organs still has a long
way to go in order to be a medically approved and accepted alternative to the traditional ways, but
there are still incredible uses of 3D and bioprinting that are currently being researched to pave the
way for greater future medical advancements such as these. 3D printing is also showing to be quite
beneficial when it comes to patient education, medical training and surgical planning.
This literature review will provide some background information on how 3D and
bioprinting works as well as their current and potential applications in fields such as orthopedics,
plastics, cardiovascular and in more general areas like patient education, medical training and
surgical planning. Though there are currently few adopted applications of 3D printing across
medical specialties, the studies presented will show that there is potential for 3D and bioprinting
to be used as a safe and efficient alternative when it comes to cardiovascular diseases. In summary,
3D and bioprinting have the capability of giving medicine the upper hand to customize
diagnostic/treatment plans that specifically meet each patient’s anatomy and overall medical needs
and this literature review seeks to delve deeper into that as it discusses some of the relevant studies.

METHODS
A comprehensive literature review was conducted using Google Scholar, Google and Trip
Database using the search terms 3D printing, bioprinting, applications in medicine, cardiovascular
diseases, orthopedic implants, burn patients and more. The inclusion criteria were studies with
primary research, studies conducted in-vivo and clinical trials. The exclusion criteria were studies
before 2017 and systematic reviews. Since studies on the application of 3D and bioprinting are
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relatively new, there were a limited number of experimental research and prospective studies that
fulfilled all the inclusion and exclusion criteria. As such, there are some sources before 2017 and
systemic review studies that were included in this literature review.

REVIEW OF LITERATURE
While traditional methods usually focus on processes like carving and molding to create
a product,3 3D printing involves the delivery of thin layers of materials such as collagen, gelatin,
alginate, hyaluronic acid (natural polymers) or PCA, polyethylene glycol (synthetic polymers) in
a sequential manner and bonding them together to form a solid 3D structure.4 3D printing for
tissue engineering is bioprinting. 3D bio-printing is a form of 3D printing whereby cells and
biomaterials which form bio-inks are used instead of traditional materials like metals and plastics
to create 3D constructs that used for functional 3D tissues. 3D bioprinting starts with a model of
a structure which is created layer-by-layer out of a bio-ink either mixed with living cells or
seeded with cells after the print is complete. Bio-ink is a hydrogel based scaffold. These starting
models can come from anywhere, a CT or MRI scan, a computer generated design (CAD)
program, or a file downloaded from the internet.4 3D bioprinting, which is basically a subset of
3D printing mostly consists of five steps: imaging or scanning of the target tissue, developing the
model from the image input with computer-aided software (CAD-CAM), choosing the
biomaterial scaffolds and cells according to the tissue type, printing the tissue using a bioprinter
and finally allowing the bioprinted tissue to mature. Bioprinting can be applied in-vitro or in-situ
settings. Most of the time, for bioprinting to be used for implantation during tissue engineering, it
requires the in-vitro setting or testing.4
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3D printing and bioprinting are emerging as a potential for technological advancement in
the various fields of medicine. By 2019, the number of US hospitals that included centralized 3D
printing facility into their medical practices increased from just 3 in 2010 to over 100.3
Specialties such orthopedic surgery, plastic surgery and even cardiovascular surgery are a few
that are applying 3D and bioprinting as well as working to have them accepted and approved to
be incorporated into medical practice. Though the technology of 3D printing seems to be clothed
with so much potential, there is a critical need to ensure that the products made via 3D and
bioprinting are safe for the patients they are intended for. Though 3D printers are not regulated
by the FDA, their products are. FDA regulation is based on the type of product, its use and
potential risk to patients.3
In 2017, there was FDA guidelines made available for customized 3D printed products
for joint replacements and cranial implants. The FDA has also cleared softwares that can be used
to fabricate 3D models of patient’s anatomy and leaves it up to medical facilities to be
responsible enough to use these softwares diligently for their intended purposes. Though it seems
that FDA guidance is lacking for 3D printing in biologic domains (bio-printing) they are covered
under the FDA’s Center for Biologics Evaluation and Research (CBER). For the medical 3D
printed products that are not directly covered under FDA regulations, the State Medical Boards
may have jurisdiction if 3D printing becomes harmful to patients. The downside is that, these
boards acts on filed complaints instead proactively leading investigations and hopefully in the
near future this can be improved upon. The Radiological Society of North America has come out
with guidelines for the application of 3D printing at the point-of-care, which ensure that 3D
printed anatomical products are safe to be used for diagnostic purposes.3
3D and bioprinting applications in orthopedic surgery
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Currently, most of the FDA-reviewed 3D medical products are in the specialty of
orthopedics.3 In orthopedics, the technology of 3D printing is being applied in surgery to make
custom joint replacements for patients instead of relying on just the traditional joint replacements
and encouraging results are being observed and recorded. One study conducted at the department
of Graduate Medical Educations and Podiatric surgery at Our Lady of Lourdes Memorial
Hospital NY, shows that the implantation of custom-made talar body for a total talar replacement
(TTR) shows encouraging results. Patients who undergo total ankle replacement (TAR) due to
avascular necrosis (AVN), ankle dislocation, arthritis, infections or tumors are compared to those
who undergo customized total talar replacements instead. In one instance, an increase in total
joint motion from 21.3° +/- 14° to 32.2°+/-11° was observed in 33 arthritic patients when they
were treated with total ankle arthroplasties using custom long-stemmed talar components after
their traditional TAR failed.5 Another instance showed that a patient-specific total talonavicular
replacement in a professional rock climber after a fracture showed good restoration of rotation
and no evidence of changes to neighboring joints of the foot during a 30-month follow-up with a
full body gait analysis and 3D joint kinematics.5
Recently published in the JAMA journal is the approval by the FDA of 3D-printed
implants designed to treat patients with avascular necrosis of the ankle joint. According to the
journal, data supporting the approval of this treatment of AVN of the ankle included results from
32 talus replacement surgeries. A 3-year follow-up from these patients through a standard
subjective scoring system showed a decrease of pain from moderate or high levels to mild levels,
as well as an overall improvement in the range of motion of the ankle joint.6 The common
adverse effect observed was only pain and scar tissue at the surgery site, which is to be expected
for almost every, if not all surgical procedures. The FDA, using the humanitarian device
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exemption process found this treatment method to be beneficial with relatively low adverse
effects.6 Since this is a relatively new form of treatment, there is the unavailability of years of
observation among patients undergoing these procedures and future results will show if there are
other complications or adverse effects associated with 3D printed implants for AVN of the ankle.
It is great to see that 3D printing is making a positive impact in the world of medicine but it is
still a relatively new medical advancement. Though the studies have shown positive results so
far, it is hard to efficiently conclude how it would still be accurately applied in the future of
medicine in cardiovascular diseases.
3D bioprinting application in skin tissues
Another area that 3D and bioprinting is growing is in the specialty of plastic surgery.
There is an ongoing research in the process of using 3D bioprinting in the reconstruction of skin
tissues that can be used in the treatment of burn wounds in patients. According to the burn and
trauma article in BMC, there are two ways of skin bioprinting which are in-situ and in-vitro.4 To
quote the source, “In the in-situ form of skin bioprinting, there is the direct printing of precultured cells onto the injury site for wound closure which allows for skin tissue maturation at
the site of the wound. This allows for precise deposition of cells on the wound, elimination of the
need for expensive and time-consuming in-vitro differentiation and the need for multiple
surgeries. In the case of in-vitro skin bioprinting, maturation of the bioprinted skin tissue is done
in a bioreactor and transplanted to the wound site after maturation.4” Other skin appendages (like
hair follicles, sweat glands, melanocytes etc.) are being evaluated in recent studies to ensure that
these bioprinted skin, function as close to natural skin as possible.4 There is still a great need for
clinical trials to ensure that 3D bioprinting can serve as a safe alternative to the traditional
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donated skins for these burn patients. Though these studies are still in the testing in-vitro stages,
it gives an idea of how 3D and bioprinting can be implemented in cardiovascular diseases.
3D bioprinting application in myocardial tissues
Cardiovascular surgery is also showing huge interest in this relatively new technology.
The technology of 3D printing is in the process of being studied to fabricate tissues of the
cardiovascular system such as the myocardium, heart valves and even in vasculature like
coronary arteries. In diseases such as congestive heart failure or coronary artery disease some of
the cardiac tissues get damaged. There is loss of cardiomyocytes and this permanently affects the
contractility of the myocardial tissues. This thus, leads to an overall decrease in cardiac output,
which eventually can lead to ischemia and then death. Traditionally, an approach to treat
damaged heart tissues is via cellular therapy. This treatment regimen is dependent on the
implanted cells’ ability to survive implantation and be incorporated into the patient’s heart
tissues. Unfortunately, the use of cellular therapy alone has not been as effective in heart tissue
regeneration due to the inability to keep up with functions of the heart.7,8 This is where the
technology of tissue engineering which includes 3D bioprinting seems to be a helpful and
promising alternative.
One study evaluates the combination of tissue printing (TP), human cardiac-derived
cardiomyocyte progenitor cells (hCMPCs) and biomaterials to investigate their cardiogenic
potential for in-vitro and in-vivo use. Human fetal cardiomyocyte progenitor cells and alginate
(biomaterial) were included in making a porous bio-scaffolder for 3D bioprinting of the tissues.
The study was able to generate a homogenous distribution of cells in the scaffolds in-vitro and
showed a cell viability of 92% and 89% on days 1 and 7.8,9 It showed that a porous structure
which is only achieved via tissue printing (bio-printing) preserved the viability of the hCMPCs
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and could potentially lead to effective cardiac tissue regeneration. To simulate an in-vivo
environment, the printed hCMPCs were placed on a Matrigel layer to stimulate cell growth from
the matrix. A few cell growths were observed after one day and tubular structures were observed
after 1 week. Viability of migrated hCMPCs was demonstrated through a live/death assay after 3
weeks in culture and few cell deaths were observed.8 This study, though it was mainly performed
in-vitro/ex-vivo, had a good control of comparing a porous scaffold to that of a non-porous
(solid) scaffold in terms of cell viability. It showed that, cell viability was preserved and free of
influence in the porous scaffold as compared to that of the solid scaffold.8 But it fails to compare
the effectiveness of tissue printing for cardiac cell regeneration to that of the traditional cellular
therapy. Another study done in-vivo involving rats with infarcted hearts was able to show that
the use of bioprinting for cardiac tissues, improved blood vessel formation, increased capillary
density and an overall improvement in the function of the heart when using spatial cell
arrangments.9
3D and bioprinting application in heart valves
Currently there are two options for heart valve replacement surgeries which includes
using a mechanical heart valve or a biological heart valve. The advantage of mechanical valves is
that they are robust and last a relatively longer time as compared to biological valves. The
disadvantage of mechanical valves is that, since they are technically a foreign material in the
body they have a tendency to trigger clotting and as such, patients are required to be on a lifelong
anticoagulants. On the other hand, biological valves which are from allographic or xenographic
sources do not require a lifetime of anticoagulants from their patients, but do tend to have a
shorter life span and increase the chances of the patient having to go through another surgery to
replace their valves.7 This is where 3D bioprinting of heart valves stand to have potential of
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being an alternative to these traditional materials and might even prove to be more beneficial for
patients in the long run. They have the potential to remove the need for anticoagulants of patients
with artificial heart valves and even have the ability to grow as the patient ages. This will be very
helpful in younger patients.
Researchers from the Technical University of Munich and University of Western
Australia, are in the process of developing 3D printed artificial heart valves seeded with the
patient’s own cells and are able to grow as the patient ages. They made use of a melt electrowriting 3D process to create porous scaffolds made up of the patient’s cells. The testing phase
was done ex-vivo by creating a mock circulatory system with exposure to the same pressures and
flow rate of a natural heart valve. An in-house melt electro-writing 3D printer was used to create
heart valve implants that mimicked an individual patient’s aortic valve. The resulting product
was capable of withstanding the demanding functions of a heart valve while still remaining
porous enough to allow the patient’s cells to colonize the scaffold and proliferate.10 Though
promising results were observed according to ISO (International Organization of
Standardization) standards, it is not the best way to explore the long-term functionality of these
3D artificial heart valves and there is the need for actual in-vivo studies and clinical trials to be
conducted.10
3D bioprinting application in vasculature
Coronary artery diseases are still a burden despite the improvement in treatment
therapies. In a procedure like a CABG which is usually indicated in patients who present with
blocked coronary arteries due to thrombosis or stenosis, blood needs to be diverted to the heart
via a different route. A conduit is often used where other vessels such as the internal thoracic
artery, radial artery or the saphenous vein is used. Though the CABG can significantly improve
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the health in the cardiovascular disease patients, about 30% of these patients are ineligible for
this surgical procedure due to a lack of suitable autologous vessels. And with patients who are
fortunate enough to have a patent vessel for the bypass there is still a risk of damage during
harvesting or graft failure.7
Earlier studies have explored the potential of artificial coronary grafts in place of native
vessels. In order to replace the native vessels efficiently, the synthesized grafts should be
biocompatible, anti-thrombogenic, durable and possess similar compliance and density as the
native grafts. The use of Gortex (expanded polytetrafluoroethylene) and Dacron (polyethylene
terephthalate), both of which are no strangers in the aorta and peripheral vessel areas have shown
disappointing results when used for small diameter and low flow coronary grafts. These synthetic
grafts showed a lack of flexibility for its intended purpose in the heart and were also found to
trigger some inflammatory responses upon exposure to blood which then led to thrombogenesis.7
Vascular tissue engineering is the new avenue being explored for artificial CABG grafts. To
engineer biomimetic vessels, a scaffold guided approach is used (which involves the use of
natural, synthetic biomaterials or decellularized matrix as scaffolds to support cell attachment,
infiltration and proliferation during the in-vitro tissue development) or a cell sheet based
approach is used (which involves a monolayer of cells being cultured and rolled on a mandrel to
produce a tubular conduit mimicking the media and adventitia of an artery). 3D printing comes
into the process of tissue engineering through the generation of scaffolds that are patient specific
in terms of geometry.7
3D printing is showing to be a potential tool that allows for the direct printing of
synthetic biomaterials by making use of differentiated endothelial cells, fibroblasts,
mesenchymal and hematopoietic stem cells, which can be used in the engineering of biomimetic

Asare-Ose 15
vessels.7 Unfortunately, research of 3D printing has not yet been applied directly to the creation
of patient-specific coronary artery bypass grafts. Another study demonstrates the power or
permeable hierarchical microchannel networks to facilitate mass exchange in tissue exchange
constructs through the maintenance of metabolic functions of heart cells in-vitro that will in turn,
facilitate angiogenesis and tissue integration, thus efficiently incorporated into the treatment of
myocardial infarction.11 This study is also done in-vitro and is yet to be applied in an in-vivo
setting.
One study looks at the potential of 3D printed sugar based stents, that helps in vascular
anastomosis in various surgery such as cardiovascular surgery. Vascular anastomosis is used in
several surgical procedures such as organ transplant surgeries. The traditional approach to
microvascular anastomosis involves stopping the blood flow using a clamp and holding the sides
of the vessels next to each other while connecting them by using microvascular sutures (8–0 or
9–0 nylon) under a microscope.1 This takes a lot of skill and speed for if the anastomosis fails, it
can lead to thrombosis thus failure in that particular surgical procedure. This process even
becomes more challenging when the vessels being connected together are of different sizes. This
is where a temporary stent to keep the vessels opened is very useful.1
A recent solution is the use of thermo-poloxamer gel to keep the vessels open during
suture-based anastomosis, but with this method, vessel blockage has not been able to be
eliminated. The use of sugar based stents for temporary stenting during such surgical procedures
show promise due to their potential to prevent thrombogenesis. The challenge with the existing
sugar based stents are the molding technique used to make them are not robust enough to
produce different dimensions to fit different patients.1 Blood vessels dimensions differ from
patient to patient and even in the same patient, the dimensions of the vessels being connected
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might be different. This makes an already challenging surgical procedure more complicated as
the surgical team has to deal with fiddling with these stents to try to make them fit perfectly in
order to get the anastomosis done. 3D printed sugar based stents makes it possible for each
patient undergoing such procedures to have a customizable sugar based stent that prevents
clotting and eliminates the issues of connecting two unequal vessels.
In this study, the goal was to develop a 3D printed sugar based stent that was non-brittle,
had the ability to dissolve following the restoration of blood flow after the surgical anastomosis
procedure and had anti-clotting abilities. Previous designs for sugar based stents that used
glucose and sucrose only, formed a more brittle glass and broke upon the exposure to mechanical
loads which made them less suitable for vascular stents. Therefore, in this study, dextran which
is medically approved by the US FDA, was added and significantly improved the ductility of the
formed sugar glass. The sugar based stents were also incorporated with sodium citrate (calcium
chelator) that helps to prevent clotting.1 This experiment was performed ex-vivo using the
femoral arteries of pigs. The study was able to show an increase in dissolution time following
blood flow, an improvement in the prevention of clots and fabricating them via 3D printing
increased production time and allowed the dimensions to be easily customized to fit specific
dimension of blood vessels. These 3D sugar based stents were also shown to have a reduced
amount of leakage when placed in the vessel which is very important during the surgical
procedures where surgical glue is used in combination to suturing.1 The downside is that, this has
not yet been performed in-vivo in humans and as such has quite a bit to go before it can be
approved as a safe and efficient alternative to the standard methods and material in surgical
anastomosis.
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When it comes to 3D and bioprinting of whole organs, the technology is still in its
infancy and has a long way to go. Recently, researchers from the Chinese Academy of Sciences
were able to 3D print a cardiac tissue that kept rhythm (labeled alive) for at about 6 months. A
six-axis robotic arm was converted into a 3D bioprinter, allowing the printing of the complexshaped blood vessel scaffolds from all angles. In addition to the converted bioprinter, the
researchers added an oil bath to replicate a more natural organ development process. They then
printed mono and multilayer cells onto the printed blood vessel scaffold and cultured them for a
period of time to elicit cell-to-cell contact which they achieved via hydrophobicity (water
repelling) and thus, enhanced the formation of new blood vessels. These scientists are working
on developing this novel approach of bioprinting to be incorporated into the creation of
functional artificial tissues and organs in an in-vitro setting and soon in in-vivo settings as well.12
Another study in Zurich is works on 3D printing to create a soft artificial heart with two
ventricles using a silicone mold that was able to beat for about 30 minutes. Using a hybrid mock
circulation, a blood flow rate of 2.2L/min against an afterload of 1.11mm/Hg s/mL was able to
be achieved.13
Finally, an area where the application of 3D printing is beneficial to medicine is in patient
education, medical training and surgical planning. Customized 3D models can be made for patients
to have a more vivid picture of where the medical problem is and how it is going to be fixed
surgically. This might make it easier for patients to understand what is going to be performed on
them in surgery instead of having to listen to a bunch of technical terms and explanations. It even
makes it easier for patients who require translations to have a better understanding when they do
not have to rely totally on their imagination but have a physical model to look at and handle. 3D
printing is also helpful for the surgical team in surgery planning to make sure they are all on the

Asare-Ose 18
same page with their surgical approach and steps. This benefit is not only limited to patient
education or surgical planning but in some areas of medical training like anatomy and vascular
access as well. A study showed that, 19 trainees undergoing femoral artery access training,
preferred the use the 3D models compared to the use of commercially simulators. The model was
created to look realistic on ultrasound imaging and even had a palpable pulse.14 Another study
sought to demonstrate the accuracy and reliability of 3D printed models in the treatment of
congenital heart diseases and states that 3D printing is reliable and suitable for the analysis of
congenital diseases of the heart. But acknowledges that these studies are still subject to the limits
of 3D printing and its potential bias.15,16 Though studies show that 3D printing could improve
medical understanding, teaching or surgical training, there are inadequate studies to distinctly
demonstrate these benefits for now.

ANALYSIS AND DISCUSSION
3D and bioprinting are relatively novel technological advancements in the field of
medicine and as such has an inadequate amount of research on its current and potential
applications. For 3D and bioprinting to be accepted as an alternative standard, there has to be the
availability of concrete data to support its safety and efficiency. Fortunately, there are some
studies that are able to show that 3D printing is actually being safely and efficiently applied in
some fields of medicine. In orthopedic surgery, studies have been able to show that 3D printed
ankle joint implants have been able to show encouraging results in patients with AVN, so much
so that the FDA has actually approved the use of 3D printed joints in ankle replacement
surgeries.5,6 So far, the 3D printed implants are proving to be safe with no direct adverse effects
but since this is relatively new, the study only has the performance of these implants over a
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relatively short period of time via patient follow-up to go off on. This is still not enough so
adjustments of the safety and functionality of this new treatment option might be better deducted
as time goes on. In the field of plastic surgery with burn patients, there are also studies going on
with skin bioprinting to be used in reconstruction surgeries. These studies are still in their testing
stage and a lot of them have not even been performed in-vivo. This makes it very challenging to
deduce the effectiveness of bioprinting in the treatment of burn wounds since no patient
population is currently being used for this study.
A lot of the studies above have only been able to highlight some of the possible
applications of 3D printing and bioprinting in cardiovascular disease via in-vitro and ex-vivo
studies. 3D and bio-printing are being studied to be used in treatments of the cardiovascular
realm such as in the tissue engineering of myocardium, heart valves, coronary arteries and many
more. Since the traditional method of cellular therapy for tissue regeneration in the face of
myocardial injury is limited, 3D bio-printing can be a way to efficiently induce the growth of
viable cell and tissues in the heart. By implementing the use of porous bioscaffolders (which
allows cells to infiltrate it better than in non-porous scaffolds) from a patient’s progenitor cells in
combination with biomaterials/bioink like alginate, cells can have a greater chance of survival.
The 3D printed bioscaffold is able to provide a cohesive mold for the seeded cells to grow and
mature efficiently. This increases the chances of a successful implantation of the mature tissue
into the patient and thus, enhance the integration of the implanted tissues into the patient’s native
myocardial tissues to help restore cardiac functions after a cardiac injury.8 The challenge is that,
since 3D printing is still fairly new it is very hard to extrapolate these studies into the patient
population of interest in order to come out with reliable data.
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Another area in cardiovascular diseases that 3D printing shows great promise is in heart
valve replacements. Currently, the treatment of heart valve dysfunctions or failures, are limited
to two options. The use of biological or mechanical valves to replace incompetent native valves.
The problem with just these two treatment options is that, with mechanical valves, it has a long
life span but it is susceptible to blood clots. This resigns the patient to a fate of lifelong anticoagulants. On the other hand, biological valves, do not require the patients to be on lifelong
anticoagulants, but they have a short lifespan and puts the patient at risk for multiple surgeries.
3D printing is being researched to produce patient-specific heart valves that grow as the patient
ages. Since these bio-printed heart valves are seeded with the patient’s cells, it is not recognized
as foreign and treated as such.9 With the valves aging with their patient, it removes the problem
of the patient outgrowing their valves and standing the risk of going into surgery for another
valve replacement.
As for the 3D printing of functioning hearts there are a number of studies taken place that
is getting this extraordinary technological advancement closer to a foreseeable future. Research
is heading in the right direction as there are 3D printed cardiac tissues that can maintain rhythm
but there is still long way to go. Though 3D printing and bio-printing shows a great potential for
its application in cardiovascular diseases, it is quite behind traditional approaches in terms of
years and data of support. There is a lack of concrete evidence to depict the actual benefits of 3D
printing in changing the outcomes of patients with cardiovascular diseases and as such there is
the need for prospective clinical studies and trials. 3D printing also shows potential to be
beneficial in medical training, patient education and surgical planning, but there is still the need
to create well-designed studies to prove this benefit.
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For tissue engineering via 3D printing to be successfully incorporated into cardiovascular
diseases, there is the need to ensure that the materials used for 3D and bioprinting are safe and
that biomaterials/bio-inks are not going to cause side effects to patients or negatively affect the
functions of other organs of the body. There is the need for studies to show results proving that
they are not just biocompatible, but in the long run, will not be harmful to crucial organs such as
the kidney and liver. With 3D printed implants of joints being so new in treatment options, not
enough time has passed to show that they have no long-term adverse effects in patients.
Biomaterials such as silicone are used constantly in plastics for breast implants but it can still not
be a concluded that the use of biomaterials as these will have no long term adverse effects.
There are so many different approaches to 3D and bioprinting that can produce different
results and all these still need to be accurately studied and tested to make sure that patients who
undergo these trials or even begin to use them, are not put in harm’s way. We need the time and
resources to explore this further in order to make sure that it is at least as safe and effective as the
traditional options. There also needs to be concrete data to show the accessibility of 3D printed
products to diverse patient populations and at a reasonable cost as well. It should be available
and accessible to patients of various socio-economic levels.

CONCLUSIONS
Though the application of 3D printing and bioprinting seems to be growing fast and can
be considered to be full of promise, they are relatively new technologies and still in need of years
of clinical trials and research. Several studies conducted in various specialties in healthcare are
showing a future for 3D and bioprinting applications in medicine and in cardiovascular diseases.
Looking at recent studies, the specialty of orthopedics seems to be at the forefront in terms of the
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actual utilization of 3D printing as a safe and efficient alternative to native materials and
methods. It is impressive to see that the FDA has been able to approve 3D printed ankle joint
replacements for patients with ankle joint AVN. In the world of cardiovascular diseases, 3D and
bioprinting still need more time in research for in-vivo studies, clinical trials and to be finally
approved and accepted as safe and efficient alternatives. Having this other option for
cardiovascular diseases will enable increased access for patients that may be faced with limited
diagnostic and treatment options due to financial, socio-economic, language or biological
barriers.
There are so many questions that need to be answered for 3D printing to be effectively
implemented into the medical practice of the cardiovascular world. For 3D and bioprinting to be
approved and adopted as efficient and safe alternatives in cardiovascular diseases, there has to be
more research conducted in in-vivo settings that go on to be incorporated into clinical trials in
order to properly assess their efficiency and safety in patients. Currently, there is a lack of such
studies and research, but it does not mean that they do not have the potential to provide this
medical benefit. The current studies, though having limitations as stated above, do show the
applicability of 3D and bioprinting in the medical field. To conclude, 3D and bioprinting, in the
near future, could serve as an efficient and safe alternative to traditional methods and materials in
cardiovascular diseases, but for now, it still needs more time to get there.
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